Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Whitehawk Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −11 vs. Q1 2025
- Shares held
- 29.4M
- −2.38M (−7.5%) vs. Q1 2025
- Total value
- $54.6M
- −$1.61M (−2.9%) vs. Q1 2025
- New holders
- 2
- 9 more added
- Sold out
- 13
- 11 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $15 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 19 | $36 | 0.00% | −1−5.0% | Reduced |
| BNP Paribas Arbitrage, SA | 160 | $299 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 232 | $432 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 358 | $669 | 0.00% | −572−61.5% | Reduced |
| Russell Investments Group, Ltd. | 386 | $722 | 0.00% | −1,126−74.5% | Reduced |
| Bank of America Corp | 411 | $769 | 0.00% | +231+128.3% | Added |
| JPMorgan Chase & Co | 421 | $787 | 0.00% | −1,341−76.1% | Reduced |
| Bartlett & Co. Wealth Management LLC | 1,333 | $2.49K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,003 | $3.75K | 0.00% | −62,234−96.9% | Reduced |
| Advisor Group Holdings, Inc. | 3,070 | $5.74K | 0.00% | −33−1.1% | Reduced |
| US Bancorp | 3,333 | $6.23K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,098 | $7.66K | 0.00% | +1,543+60.4% | Added |
| UBS Group AG | 8,673 | $16.2K | 0.00% | −26,894−75.6% | Reduced |
| Two Sigma Securities, LLC | 11,103 | $20.8K | 0.00% | +11,103 | New |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $49.9K | 100.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 28,538 | $53.4K | 0.00% | −68,774−70.7% | Reduced |
| Squarepoint Ops LLC | 61,366 | $114.8K | 0.00% | +61,366 | New |
| State Street Corp | 68,737 | $128.5K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 70,749 | $132.3K | 0.00% | −36,771−34.2% | Reduced |
| Northern Trust Corp | 92,275 | $172.6K | 0.00% | +5,952+6.9% | Added |
| Jane Street Group, LLC | 105,310 | $196.9K | 0.00% | +78,650+295.0% | Added |
| Peapod Lane Capital LLC | 242,210 | $452.9K | 0.45% | +807+0.3% | Added |
| BlackRock, Inc. | 298,320 | $557.9K | 0.00% | +57,071+23.7% | Added |
| Bridgeway Capital Management, LLC | 315,284 | $589.6K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 372,334 | $696.4K | 0.00% | +136,494+57.9% | Added |
| Renaissance Technologies LLC | 458,222 | $856.9K | 0.00% | −3,900−0.8% | Reduced |
| Ally Bridge Group (NY) LLC | 817,939 | $1.53M | 1.27% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,091,417 | $2.04M | 0.12% | −990,583−47.6% | Reduced |
| Acorn Capital Advisors, LLC | 1,139,363 | $2.13M | 1.39% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,315,285 | $2.46M | 0.00% | +549,293+71.7% | Added |
| Fan Yu | 2,070,000 | $3.87M | 5.29% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $3.89M | 0.20% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $5.33M | 0.09% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $6.38M | 8.90% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $6.92M | 0.26% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $7.79M | 0.20% | 00.0% | Unchanged |
| QVT Financial LP | 4,615,709 | $8.20M | 1.15% | +100,000+2.2% | Added |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −1,890,245−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −52,486−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −46,698−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −44,823−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −43,158−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −40,969−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −36,774−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,197−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Semmax Financial Advisors Inc. | 0 | $0 | 0.00% | −297−100.0% | Sold out |